At the transcriptional level, APOO overexpression led to elevated CCR7 while reducing CDK6, SP100, FOXP1, and ANXA1 levels in ITP patient-derived CD4+CCR7+T cells, consistent with our expectations (Figure 4F). This evidence concerns the gene ANXA1 and autoimmune thrombocytopenic purpura.